View Item 

Show simple item record

Dementia
dc.contributor.authorHallam, Danial K.
dc.contributor.authorSalamon‐muramaya, Noriko
dc.date.accessioned2018-08-13T18:52:09Z
dc.date.available2018-08-13T18:52:09Z
dc.date.issued2002-09
dc.identifier.citationHallam, Danial K.; Salamon‐muramaya, Noriko (2002). "Dementia." Current Protocols in Magnetic Resonance Imaging 6(1): A5.3.1-A5.3.18.
dc.identifier.issn2572-5637
dc.identifier.issn2572-5637
dc.identifier.urihttps://hdl.handle.net/2027.42/145357
dc.description.abstractThis unit presents specific protocols intended to maximize the contribution of MRI to the clinical evaluation of dementia. Each protocol has, as its foundation, a wholeâ brain screen designed to evaluate for treatable causes of dementia. Reflecting the frequent overlap of vascular disease with dementing illness, the screening protocol also serves as an optimal evaluation of the patient with suspected vascular dementia. Additional sequences or modifications are then used to answer specific clinical questions. The parameters given here are derived from experience at 1.5 T and may need to be altered slightly depending on the field strength and the equipment manufacturer.
dc.publisherMcGrawâ Hill
dc.publisherWiley Periodicals, Inc.
dc.titleDementia
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelFamily Medicine and Primary Care
dc.subject.hlbsecondlevelRadiology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145357/1/cpmia0503.pdf
dc.identifier.doi10.1002/0471142719.mia0503s06
dc.identifier.sourceCurrent Protocols in Magnetic Resonance Imaging
dc.identifier.citedreferenceScheltens, P., Leys, D., Barkhof, F., Huglo, D., Weinstein, H.C., Vermersch, P., Kuiper, M., Steinling, M., Wolters, E.C., and Valk, J. 1992. Atrophy of medial temporal lobes on MRI in â probableâ Alzheimer’s disease and normal ageing: Diagnostic value and neuropsychological correlates. J. Neurol. Neurosurg. Psychiatry 55: 967 â 972.
dc.identifier.citedreferenceSavoiardo, M., Strada, L., Girotti, F., D’Incerti, L., Sberna, M., Soliveri, P., and Balzarini, L. 1989. MR imaging in progressive supranuclear palsy and Shyâ Drager syndrome. J. Comput. Assist. Tomogr. 13: 555 â 560.
dc.identifier.citedreferenceSavoiardo, M., Strada, L., Girotti, F., Zimmerman, R.A., Grisoli, M., Testa, D., and Petrillo, R. 1990. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 174: 693 â 696.
dc.identifier.citedreferenceSavoiardo, M., Strada, L., Oliva, D., Girotti, F., and D’Incerti, L. 1991. Abnormal MRI signal in the rigid form of Huntington’s disease. J. Neurol. Neurosurg. Psychiatry 54: 888 â 891.
dc.identifier.citedreferenceSchoenberg, B.S., Kokmen, E., and Okazaki, H. 1987. Alzheimer’s disease and other dementing illnesses in a defined United States population: Incidence rates and clinical features. Ann. Neurol. 22: 724 â 729.
dc.identifier.citedreferenceShellock, F.G. and Kanal, E. 1996. Magnetic Resonance Bioeffects, Safety and Patient Management. Lippincott Raven, Philadelphia.
dc.identifier.citedreferenceSimmons, J.T., Pastakia, B., Chase, T.N., and Shults, C.W. 1986. Magnetic resonance imaging in Huntington disease. A.J.N.R. 7: 25 â 28.
dc.identifier.citedreferenceSohn, Y.H., Jeong, Y., Kim, H.S., Im, J.H., and Kim, J.S. 2000. The brain lesion responsible for Parkinsonism after carbon monoxide poisoning. Arch. Neurol. 57: 1214 â 1218.
dc.identifier.citedreferenceSoliveri, P., Monza, D., Paridi, D., Radice, D., Grisoli, M., Testa, D., Savoiardo, M., and Girotti, F. 1999. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 53: 502 â 507.
dc.identifier.citedreferenceSquire, L.R. 1992. Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99: 195 â 231.
dc.identifier.citedreferenceStarkstein, S.E., Brandt, J., Bylsma, F., Peyser, C., Folstein, M., and Folstein, S.E. 1992. Neuropsychological correlates of brain atrophy in Huntington’s disease: A magnetic resonance imaging study. Neuroradiology 34: 487 â 489.
dc.identifier.citedreferenceStern, M.B., Braffman, B.H., Skolnick, B.E., Hurtig, H.I., and Grossman, R.I. 1989. Magnetic resonance imaging in Parkinson’s disease and Parkinsonian syndromes. Neurology 39: 1524 â 1526.
dc.identifier.citedreferenceVerslegers, W., Van den Kerchove, M., Crols, R., De Potter, W., Appel, B., and Lowenthal, A. 1988. Methanol intoxication. Parkinsonism and decreased Metâ enkephalin levels due to putaminal necrosis. Acta. Neurol. Belg. 88: 163 â 171.
dc.identifier.citedreferenceYock, D.H. 1995. Magnetic Resonance Imaging of CNS Diseaseâ A Teaching File. p. 281. Mosbyâ Year Book, Inc. (cases 455 and 456).
dc.identifier.citedreferenceZijlmans, J.C., Thijssen, H.O., Vogels, O.J., Kremer, H.P., Poels, P.J., Schoonderwaldt, H.C., Merx, J.L., Van ’t Hof, M.A., Thien, T., and Horstink, M.W. 1995. MRI in patients with suspected vascular Parkinsonism. Neurology 45: 2183 â 2188.
dc.identifier.citedreferenceShellock and Kanal, 1996.See above.
dc.identifier.citedreferenceTerry, R.D., Katzman, R., and Bick, K.L. 1999. Alzheimer Disease, 2nd Edition. Lippincott Williams & Wilkins, Philadelphia.
dc.identifier.citedreferenceAdams, R.D., Victor, M., and Ropper, A.H. 1997. Principles of Neurology. McGrawâ Hill, New York.
dc.identifier.citedreferenceAylward, E.H., Brandt, J., Codori, A.M., Mangus, R.S., Barta, P.E., and Harris, G.J. 1994. Reduced basal ganglia volume associated with the gene for Huntington’s disease in asymptomatic atâ risk persons. Neurology 44: 823 â 828.
dc.identifier.citedreferenceAylward, E.H., Li, Q., Stine, O.C., Ranen, N., Sherr, M., Barta, P.E., Bylsma, F.W., Pearlson, G.D., and Ross, C.A. 1997. Longitudinal change in basal ganglia volume in patients with Huntington’s disease. Neurology 48: 394 â 399.
dc.identifier.citedreferenceAylward, E.H., Anderson, N.B., Bylsma, F.W., Wagster, M.V., Barta, P.E., Sherr, M., Feeney, J., Davis, A., Rosenblatt, A., Pearlson, G.D., and Ross, C.A. 1998. Frontal lobe volume in patients with Huntington’s disease. Neurology 50: 252 â 258.
dc.identifier.citedreferenceBarclay, L.L., Linden, C., and Murtagh, R. 1992. Medial temporal atrophy as a magnetic resonance imaging marker for Alzheimer’s disease. J. Neuroimaging 2: 131 â 135.
dc.identifier.citedreferenceBergeron, C., Pollanen, M.S., Weyer, L., Black, S.E., and Lang, A.E. 1996. Unusual clinical presentations of corticalâ basal ganglionic degeneration. Ann. Neurol. 40: 893 â 900.
dc.identifier.citedreferenceBraffman, B.H. 2000. The aging brain and neurodegenerative disorders. In Neuroimaging: Clinical and Physical Principles ( R.A. Zimmerman, W.A. Gibby, and R.F. Carmody, eds.)pp. 951 â 978. Springer, New York.
dc.identifier.citedreferenceBraffman, B.H., Grossman, R.I., Goldberg, H.I., Stern, M.B., Hurtig, H.I., Hackney, D.B., Bilaniuk, L.T., and Zimmerman, R.A. 1989. MR imaging of Parkinson disease with spinâ echo and gradientâ echo sequences. A.J.R. 152: 159 â 165.
dc.identifier.citedreferenceCarella, F., Grassi, M.P., Savoiardo, M., Contri, P., Rapuzzi, B., and Mangoni, A. 1988. Dystonicâ Parkinsonian syndrome after cyanide poisoning: Clinical and MRI findings. J. Neurol. Neurosurg. Psychiatry 51: 1345 â 1348.
dc.identifier.citedreferenceChawluk, A. 1999. Neuroimaging of normal brain aging and dementia. In Neuroimaging: A Companion to Adams and Victor’s Principles of Neurology ( J.O. Greenberg, ed.)pp. 301 â 332. McGrawâ Hill, New York.
dc.identifier.citedreferenceChoi, I.S. and Cheon, H.Y. 1999. Delayed movement disorders after carbon monoxide poisoning. Eur. Neurol. 42: 141 â 144.
dc.identifier.citedreferenceConvit, A., De Leon, M.J., Tarshish, C., De Santi, S., Tsui, W., Rusinek, H., and George, A. 1997. Specific hippocampal volume reductions in individuals at risk for Alzheimer’s disease. Neurobiol. Aging 18: 131 â 138.
dc.identifier.citedreferenceCooper, B. 1994. Health care policy and planning for dementia: An international perspective. In Dementia and Normal Aging ( F.A. Huppeit and D.W. O’Conner, eds.)pp. 519 â 551. Cambridge University Press Cambridge.
dc.identifier.citedreferenceCurran, T. and Lang, A.E. 1994. Parkinsonian syndromes associated with hydrocephalus: Case reports, a review of the literature, and pathophysiological hypotheses. Mov. Disord. 9: 508 â 520.
dc.identifier.citedreferenceDavis, P.H., Bergeron, C., and McLachlan, D.R. 1985. Atypical presentation of progressive supranuclear palsy. Ann. Neurol. 17: 337 â 343.
dc.identifier.citedreferenceDe Leon, M.J., George, A.E., Stylopoulos, L.A., Smith, G., and Miller, D.C. 1989. Early marker for Alzheimer’s disease: The atrophic hippocampus. Lancet 2: 672 â 673.
dc.identifier.citedreferenceDuguid, J.R., De La Paz, R., and DeGroot, J. 1986. Magnetic resonance imaging of the midbrain in Parkinson’s disease. Ann. Neurol. 20: 744 â 747.
dc.identifier.citedreferenceEvans, D.A., Funkenstein, H.H., Albert, M.S., Scherr, P.A., Cook, N.R., Chown, M.J., Hebert, L.E., Hennekens, C.H., and Taylor, J.O. 1989. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA 262: 2551 â 2556.
dc.identifier.citedreferenceFlicker, C., Ferris, S.H., and Reisberg, B. 1991. Mild cognitive impairment in the elderly: Predictors of dementia. Neurology 41: 1006 â 1009.
dc.identifier.citedreferenceFriedman, J.H. 1996. Walkingâ induced Parkinsonism due to presumed idiopathic normal pressure hydrocephalus. Mov. Disord 11: 99 â 101.
dc.identifier.citedreferenceFrisoni, G.B., Beltramello, A., Weiss, C., Geroldi, C., Bianchetti, A., and Trabucchi, M. 1996. Linear measures of atrophy in mild Alzheimer disease. A.J.N.R. 17: 913 â 923.
dc.identifier.citedreferenceHarris, G.J., Pearlson, G.D., Peyser, C.E., Aylward, E.H., Roberts, J., Barta, P.E., Chase, G.A., and Folstein, S.E. 1992. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington’s disease. Ann. Neurol. 31: 69 â 75.
dc.identifier.citedreferenceHollister, L.E. and Boutros, N. 1991. Clinical use of CT and MR scans in psychiatric patients. J. Psychiatry Neurosci. 16: 194 â 198.
dc.identifier.citedreferenceJack, C.R. Jr., Petersen, R.C., Xu, Y.C., Waring, S.C., O’Brien, P.C., Tangalos, E.G., Smith, G.E., Ivnik, R.J., and Kokmen, E. 1997. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49: 786 â 794.
dc.identifier.citedreferenceJack, C.R. Jr., Petersen, R.C., Xu, Y.C., O’Brien, P.C., Smith, G.E., Ivnik, R.J., Boeve, B.F., Waring, S.C., Tangalos, E.G., and Kokmen, E. 1999. Prediction of AD with MRIâ based hippocampal volume in mild cognitive impairment. Neurology 52: 1397 â 1403.
dc.identifier.citedreferenceKaye, J.A., Swihart, T., Howieson, D., Dame, A., Moore, M.M., Karnos, T., Camicioli, R., Ball, M., Oken, B., and Sexton, G. 1997. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 48: 1297 â 1304.
dc.identifier.citedreferenceKrauss, J.K., Regel, J.P., Droste, D.W., Orszagh, M., Borremans, J.J., and Vach, W. 1997. Movement disorders in adult hydrocephalus. Mov. Disord. 12: 53 â 60.
dc.identifier.citedreferenceLang, A.E., Curran, T., Provias, J., and Bergeron, C. 1994. Striatonigral degeneration: Iron deposition in putamen correlates with the slitâ like void signal of magnetic resonance imaging. Can. J. Neurol. Sci. 21: 311 â 318.
dc.identifier.citedreferenceLarson, E.B., Reifler, B.V., Sumi, S.M., Canfield, C.G., and Chinn, N.M. 1986. Diagnostic tests in the evaluation of dementia. A prospective study of 200 elderly outpatients. Arch. Intern. Med. 146: 1917 â 1922.
dc.identifier.citedreferenceLee, M.S. and Marsden, C.D. 1994. Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings. Mov. Disord. 9: 550 â 558.
dc.identifier.citedreferenceLey, C.O. and Gali, F.G. 1983. Parkinsonian syndrome after methanol intoxication. Eur. Neurol. 22: 405 â 409.
dc.identifier.citedreferenceMessing, B. and Storch, B. 1988. Computer tomography and magnetic resonance imaging in cyanide poisoning. Eur. Arch. Psychiatry Neurol. Sci. 237: 139 â 143.
dc.identifier.citedreferenceMiodrag, A., Das, T.K., and Shepherd, R.J. 1987. Normal pressure hydrocephalus presenting as Parkinson’s syndrome. Postgrad. Med. J. 63: 113 â 115.
dc.identifier.citedreferenceOlanow, C.W. 1992. Magnetic resonance imaging in Parkinsonism. Neurol. Clin. 10: 405 â 420.
dc.identifier.citedreferencePearson, D.W., Durward, W.F., Fogelman, I., Boyle, I.T., and Beastall, G. 1981. Pseudohypoparathyroidism presenting as severe Parkinsonism. Postgrad. Med. J. 57: 445 â 447.
dc.identifier.citedreferenceRosenberg, N.L., Myers, J.A., and Martin, W.R. 1989. Cyanideâ induced Parkinsonism: Clinical, MRI, and 6â fluorodopa PET studies. Neurology 39: 142 â 144.
dc.identifier.citedreferenceRutledge, J.N., Hilal, S.K., Silver, A.J., Defendini, R., and Fahn, S. 1987. Study of movement disorders and brain iron by MR. A.J.R. 149: 365 â 379.
dc.identifier.citedreferenceRydberg, J.N., Riederer, S.J., Rydberg, C.H., and Jack, C.R. 1995. Contrast optimization of fluidâ attenuated inversion recovery (FLAIR) imaging. Magn. Reson. Med. 34: 868 â 877.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cpmia0503.pdf
Size:
760.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.